Arkolith/Insider Trading/IMGO/Form 4

Chiang Hsiangyi

Senior Vice President, FinanceImago BioSciences, Inc. (IMGO) · full profile →Form 4 · filed Jan 11, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
4
1 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 11, 2023Tender(U)27K$36.00$955K0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 11, 2023Disposed to issuer(D)92K——0
Jan 11, 2023Disposed to issuer(D)24K——0
Jan 11, 2023Disposed to issuer(D)86K——0

Transaction Codes

U
See SEC Form 4 code table
D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000899243-23-001590) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML